Siranjeevi Nagaraj

721 total citations
16 papers, 500 citations indexed

About

Siranjeevi Nagaraj is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Siranjeevi Nagaraj has authored 16 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Cancer Research. Recurrent topics in Siranjeevi Nagaraj's work include Alzheimer's disease research and treatments (7 papers), MicroRNA in disease regulation (6 papers) and RNA Research and Splicing (3 papers). Siranjeevi Nagaraj is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), MicroRNA in disease regulation (6 papers) and RNA Research and Splicing (3 papers). Siranjeevi Nagaraj collaborates with scholars based in Poland, Belgium and Spain. Siranjeevi Nagaraj's co-authors include Katarzyna Laskowska-Kaszub, Urszula Wojda, Katarzyna Marta Zoltowska, Konrad J. Dębski, Jacek Kuźnicki, Joanna Wojsiat, Tomasz Gabryelewicz, Michał Dąbrowski, Celia Kjærby and Jillian Iafrati and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecular Psychiatry.

In The Last Decade

Siranjeevi Nagaraj

15 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siranjeevi Nagaraj Poland 7 258 152 148 83 80 16 500
Yosef Avchalumov United States 14 201 0.8× 83 0.5× 65 0.4× 67 0.8× 56 0.7× 26 473
Kyongman An South Korea 8 319 1.2× 179 1.2× 116 0.8× 37 0.4× 19 0.2× 9 562
Karen M. J. van Loo Germany 15 320 1.2× 65 0.4× 74 0.5× 39 0.5× 40 0.5× 35 595
Niamh C. O’Sullivan Ireland 13 270 1.0× 53 0.3× 83 0.6× 28 0.3× 48 0.6× 22 581
Wenjie Mao United States 10 291 1.1× 38 0.3× 149 1.0× 42 0.5× 77 1.0× 19 513
Faraz Sultan United States 11 441 1.7× 62 0.4× 84 0.6× 66 0.8× 16 0.2× 15 704
Virve Kärkkäinen Finland 11 239 0.9× 34 0.2× 66 0.4× 85 1.0× 49 0.6× 24 482
Eva M. Pérez-Villegas Spain 17 422 1.6× 81 0.5× 56 0.4× 57 0.7× 24 0.3× 25 758
Philipp Follert France 6 227 0.9× 152 1.0× 71 0.5× 53 0.6× 13 0.2× 7 475
Katelin P. Patterson United States 11 370 1.4× 87 0.6× 33 0.2× 70 0.8× 31 0.4× 15 768

Countries citing papers authored by Siranjeevi Nagaraj

Since Specialization
Citations

This map shows the geographic impact of Siranjeevi Nagaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siranjeevi Nagaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siranjeevi Nagaraj more than expected).

Fields of papers citing papers by Siranjeevi Nagaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siranjeevi Nagaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siranjeevi Nagaraj. The network helps show where Siranjeevi Nagaraj may publish in the future.

Co-authorship network of co-authors of Siranjeevi Nagaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Siranjeevi Nagaraj. A scholar is included among the top collaborators of Siranjeevi Nagaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siranjeevi Nagaraj. Siranjeevi Nagaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cuevas, Eva P., Enrique López Madruga, David Ramírez, et al.. (2025). MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiology of Disease. 208. 106871–106871. 2 indexed citations
2.
Ando, Kunié, et al.. (2025). Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model. Biomolecules. 15(2). 159–159. 2 indexed citations
3.
Ando, Kunié, Siranjeevi Nagaraj, Ana Raquel Ramos, et al.. (2025). Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer’s Disease: Implications for Autophagy Dysfunction. International Journal of Molecular Sciences. 26(12). 5827–5827.
4.
Ando, Kunié, Fahri Küçükali, Siranjeevi Nagaraj, et al.. (2024). Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression. Acta Neuropathologica. 147(1). 94–94. 5 indexed citations
5.
Nagaraj, Siranjeevi, et al.. (2024). Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease. Frontiers in Molecular Neuroscience. 17. 2 indexed citations
6.
Nagaraj, Siranjeevi, et al.. (2024). miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels. Scientific Reports. 14(1). 4237–4237. 1 indexed citations
7.
Andrzejewska, A, Renata Grzela, Siranjeevi Nagaraj, et al.. (2023). Mesenchymal stem cell engineering by ARCA analog-capped mRNA. Molecular Therapy — Nucleic Acids. 33. 454–468. 5 indexed citations
8.
Ando, Kunié, et al.. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells. 11(24). 3994–3994. 50 indexed citations
9.
Nagaraj, Siranjeevi, et al.. (2022). RNA sensor response in HeLa cells for transfected mRNAs prepared in vitro by SP6 and HiT7 RNA polymerases: A comparative study. Frontiers in Bioengineering and Biotechnology. 10. 1017934–1017934. 6 indexed citations
10.
Nagaraj, Siranjeevi, Andrew Want, Katarzyna Laskowska-Kaszub, et al.. (2021). Candidate Alzheimer’s Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. International Journal of Molecular Sciences. 22(7). 3653–3653. 34 indexed citations
11.
Palomo, Valle, et al.. (2019). TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis. ACS Chemical Neuroscience. 10(3). 1183–1196. 39 indexed citations
12.
Nagaraj, Siranjeevi, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, & Urszula Wojda. (2018). microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Research Reviews. 49. 125–143. 92 indexed citations
13.
Martínez‐González, Loreto, et al.. (2018). Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients. Molecular Neurobiology. 56(4). 2424–2432. 27 indexed citations
14.
Brumback, Audrey C., Celia Kjærby, Jillian Iafrati, et al.. (2017). Identifying specific prefrontal neurons that contribute to autism-associated abnormalities in physiology and social behavior. Molecular Psychiatry. 23(10). 2078–2089. 116 indexed citations
15.
Nagaraj, Siranjeevi. (2017). Pros and Cons of miRNAs as Non-Invasive Circulatory Biomarkers. 5(1). 1 indexed citations
16.
Nagaraj, Siranjeevi, Katarzyna Laskowska-Kaszub, Konrad J. Dębski, et al.. (2017). Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects. Oncotarget. 8(10). 16122–16143. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yosef Avchalumov Breakdown of academic impact, for papers by Kyongman An Breakdown of academic impact, for papers by Karen M. J. van Loo Breakdown of academic impact, for papers by Niamh C. O’Sullivan Breakdown of academic impact, for papers by Wenjie Mao Breakdown of academic impact, for papers by Faraz Sultan Breakdown of academic impact, for papers by Virve Kärkkäinen Breakdown of academic impact, for papers by Eva M. Pérez-Villegas Breakdown of academic impact, for papers by Philipp Follert Breakdown of academic impact, for papers by Katelin P. Patterson
Rankless by CCL
2026